When the American Psychiatric Association released DSM-5 in 2013, one of the quietest and most consequential changes was the removal of the bereavement exclusion from major depressive disorder. Under the old rule, a clinician could not diagnose major depression if the symptoms appeared within two months of a loved one’s death. Under the new rule, they could. The change was defended on clinical grounds and remains controversial among the psychiatrists who have to live with it, including some who served on the DSM committees that approved it. The criticisms have aged well, and the experience of grieving people deserves to be taken seriously.
What changed and why
The bereavement exclusion existed because the symptoms of profound grief — sleep disruption, appetite loss, difficulty concentrating, withdrawal, hopelessness — overlap almost completely with the diagnostic criteria for major depression. Grieving was treated as a normal human response that mimicked but was not pathology. DSM-5’s authors argued that clinically significant depression following loss looked similar to depression in any other context, and that withholding diagnosis denied patients access to treatment. Critics, including DSM-IV chair Allen Frances and grief researchers like Jerome Wakefield and Holly Prigerson, argued the change pathologized normal grief, expanded the population eligible for antidepressants, and ignored the reality that bereavement-related distress generally resolves on its own without medication.
The clinical and cultural cost
What followed was predictable. Grieving patients who would once have been told their reaction was painful but expected can now be diagnosed with major depression in the first weeks after a death and prescribed SSRIs as a default response. The pharmaceutical industry did not need to lobby for this; the diagnostic change did the work. Grief, which is not a disease, became a billable condition. Beyond the medication question, the cultural signal matters: telling people that two weeks of intense sadness after losing a parent meets the criteria for a mental disorder reframes ordinary human experience as malfunction. Mourners already struggle to find time, social space, and acknowledgment for grief in modern life. A diagnostic system that nudges them toward “you have an illness, here is medication” instead of “this is grief and it takes time” makes that worse.
Where the line should sit
This is not an argument that grief never becomes pathological. Prolonged Grief Disorder, added to DSM-5-TR in 2022, recognizes a real and distinct condition in which grief fails to integrate over months and years and produces persistent dysfunction. That diagnosis, with its higher threshold and longer time frame, is the responsible way to identify people who genuinely need clinical intervention. Removing the bereavement exclusion from major depression went the opposite direction — pulling normal grief inside the diagnostic boundary instead of carving out the smaller subset of grief that’s truly pathological. The newer category exists. The older fix should be reconsidered.
The takeaway
Grief deserves time, support, and, when it persists abnormally, professional care. It does not deserve to be diagnosed as depression on day fifteen because a manual was streamlined. The bereavement exclusion was crude, but it protected something the current system has trouble seeing: that sadness after loss is, in almost every case, not a disorder.
Leave a Reply